Terms: = Uterine cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Treatment
23 results:
1. Prognosis and adjuvant chemotherapy for patients with malignant peritoneal cytology in early-stage non-endometrioid endometrial cancer.
Tang X; Li N; Hu Y
Eur J Surg Oncol; 2023 Nov; 49(11):107071. PubMed ID: 37708662
[TBL] [Abstract] [Full Text] [Related]
2. Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors.
Liu Y; Mullangi S; Debono D; Chen X; Pham T; Fisch MJ; Gordon AS; Hershman DL
JCO Oncol Pract; 2023 Sep; 19(9):731-740. PubMed ID: 37384847
[TBL] [Abstract] [Full Text] [Related]
3. Meta-Analysis of Survival Effects of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1).
Jeong SY; Lee KJ; Cha J; Park SY; Kim HS; Kim JH; Lee JJ; Kim N; Park ST
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557069
[TBL] [Abstract] [Full Text] [Related]
4. Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT).
Vallely AJB; Saville M; Badman SG; Gabuzzi J; Bolnga J; Mola GDL; Kuk J; Wai M; Munnull G; Garland SM; Brotherton JML; Kelly-Hanku A; Morgan C; Toliman PJ; Kombati Z; Kariwiga G; Babona D; Tan G; Simms KT; Cornall AM; Tabrizi SN; Wand H; Guy R; Canfell K; Kaldor JM
Lancet Glob Health; 2022 Sep; 10(9):e1336-e1346. PubMed ID: 35878625
[TBL] [Abstract] [Full Text] [Related]
5. Characterizing isolated tumor cells in regional lymph nodes of early endometrial cancer.
Matsuo K; Khetan VU; Brunette LL; Jooya ND; Klar M; Wright JD; Roman LD
Gynecol Oncol; 2022 May; 165(2):264-269. PubMed ID: 35232589
[TBL] [Abstract] [Full Text] [Related]
6. Socioeconomic disparities in endometrial cancer survival in Germany: a survival analysis using population-based cancer registry data.
Bedir A; Abera SF; Vordermark D; Medenwald D
J Cancer Res Clin Oncol; 2022 May; 148(5):1087-1095. PubMed ID: 35064816
[TBL] [Abstract] [Full Text] [Related]
7. Pattern of relapse in patients with stage IB1 cervical cancer after radical hysterectomy as primary treatment. Minimally invasive surgery vs. open approach. Systematic review and meta-analysis.
Manzour N; Núñez-Cordoba JM; Chiva L; Chacón E; Boria F; Vara-García J; Rodriguez-Velandia YP; Minguez JA; Alcazar JL
Gynecol Oncol; 2022 Feb; 164(2):455-460. PubMed ID: 34848071
[TBL] [Abstract] [Full Text] [Related]
8. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
Spinillo A; Dominoni M; Boschi AC; Cesari S; Fiandrino G; Gardella B
Gynecol Oncol; 2020 Dec; 159(3):630-635. PubMed ID: 33041069
[TBL] [Abstract] [Full Text] [Related]
9. Risks of Second Primary Gynecologic cancers following Ovarian cancer treatment in Asian Ethnic Subgroups in the United States, 2000-2016.
Mukand NH; Zolekar A; Ko NY; Calip GS
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2220-2229. PubMed ID: 32856609
[TBL] [Abstract] [Full Text] [Related]
10. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.
Fraison E; Kostova E; Moran LJ; Bilal S; Ee CC; Venetis C; Costello MF
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD005552. PubMed ID: 32794179
[TBL] [Abstract] [Full Text] [Related]
11. Adjuvant vaginal brachytherapy and chemotherapy versus pelvic radiotherapy in early-stage endometrial cancer: Outcomes by risk factors.
Tatebe K; Hasan Y; Son CH
Gynecol Oncol; 2019 Dec; 155(3):429-435. PubMed ID: 31610885
[TBL] [Abstract] [Full Text] [Related]
12. How Do Women Interpret the NHS Information Leaflet about Cervical cancer Screening?
Okan Y; Petrova D; Smith SG; Lesic V; Bruine de Bruin W
Med Decis Making; 2019 Oct; 39(7):738-754. PubMed ID: 31556840
[No Abstract] [Full Text] [Related]
13. Effect of radiotherapy on the survival of cervical cancer patients: An analysis based on SEER database.
Yang J; Cai H; Xiao ZX; Wang H; Yang P
Medicine (Baltimore); 2019 Jul; 98(30):e16421. PubMed ID: 31348242
[TBL] [Abstract] [Full Text] [Related]
14. CKD-602, a topoisomerase I inhibitor, induces apoptosis and cell-cycle arrest and inhibits invasion in cervical cancer.
Lee S; Ho JY; Liu JJ; Lee H; Park JY; Baik M; Ko M; Lee SU; Choi YJ; Hur SY
Mol Med; 2019 May; 25(1):23. PubMed ID: 31138113
[TBL] [Abstract] [Full Text] [Related]
15. Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome.
Scholl S; Popovic M; de la Rochefordiere A; Girard E; Dureau S; Mandic A; Koprivsek K; Samet N; Craina M; Margan M; Samuels S; Zijlmans H; Kenter G; Hillemanns P; Dema S; Dema A; Malenkovic G; Djuran B; Floquet A; Garbay D; Guyon F; Colombo PE; Fabbro M; Kerr C; Ngo C; Lecuru F; Campo ERD; Coutant C; Marchal F; Mesgouez-Nebout N; Fourchotte V; Feron JG; Morice P; Deutsch E; Wimberger P; Classe JM; Gleeson N; von der Leyen H; Minsat M; Dubot C; Gestraud P; Kereszt A; Nagy I; Balint B; Berns E; Jordanova E; Saint-Jorre N; Savignoni A; Servant N; Hupe P; de Koning L; Fumoleau P; Rouzier R; Kamal M
EBioMedicine; 2019 May; 43():253-260. PubMed ID: 30952619
[TBL] [Abstract] [Full Text] [Related]
16. Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease.
Kyrgiou M; Athanasiou A; Kalliala IEJ; Paraskevaidi M; Mitra A; Martin-Hirsch PP; Arbyn M; Bennett P; Paraskevaidis E
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012847. PubMed ID: 29095502
[TBL] [Abstract] [Full Text] [Related]
17. Concurrent paclitaxel/cisplatin chemoradiotherapy with or without consolidation chemotherapy in high-risk early-stage cervical cancer patients following radical hysterectomy: preliminary results of a phase III randomized study.
Zhao H; Li L; Su H; Lin B; Zhang X; Xue S; Fei Z; Zhao L; Pan Q; Jin X; Xie C
Oncotarget; 2016 Oct; 7(43):70969-70978. PubMed ID: 27391158
[TBL] [Abstract] [Full Text] [Related]
18. Validated competing event model for the stage I-II endometrial cancer population.
Carmona R; Gulaya S; Murphy JD; Rose BS; Wu J; Noticewala S; McHale MT; Yashar CM; Vaida F; Mell LK
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):888-98. PubMed ID: 24969798
[TBL] [Abstract] [Full Text] [Related]
19. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer.
Makino H; Kato H; Furui T; Morishige K; Kanematsu M
J Obstet Gynaecol Res; 2014 Apr; 40(4):1098-104. PubMed ID: 24320754
[TBL] [Abstract] [Full Text] [Related]
20. Phase II study of belotecan (CKD 602) as a single agent in patients with recurrent or progressive carcinoma of uterine cervix.
Hwang JH; Lim MC; Seo SS; Park SY; Kang S
Jpn J Clin Oncol; 2011 May; 41(5):624-9. PubMed ID: 21355002
[TBL] [Abstract] [Full Text] [Related]
[Next]
